These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28460113)

  • 1. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey.
    Rossignol P; Lamiral Z; Frimat L; Girerd N; Duarte K; Ferreira J; Chanliau J; Castin N
    Nephrol Dial Transplant; 2017 Dec; 32(12):2112-2118. PubMed ID: 28460113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).
    Ni Z; Jin H; Lu R; Zhang L; Yao L; Shao G; Zuo L; Qin S; Zhang X; Zhang Q; Yu W; Luo Q; Ren Y; Peng H; Xiao J; Yang Q; Chen Q; Shi Y;
    BMC Nephrol; 2023 Aug; 24(1):233. PubMed ID: 37559023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K).
    Ni Z; Jin H; Lu R; Zuo L; Yu W; Ren Y; Yang Q; Xiao J; Zhang Q; Zhang L; Zhang X; Chen Q; Chen C; Shao G; Luo Q; Yao L; Qin S; Peng H; Zhao Q;
    BMJ Open; 2021 Dec; 11(12):e055770. PubMed ID: 34937724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study.
    Agiro A; Duling I; Eudicone J; Davis J; Brahmbhatt YG; Cooper K
    Hemodial Int; 2022 Jul; 26(3):397-407. PubMed ID: 35037388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol.
    Zhao X; Zuo L
    BMJ Open; 2023 Sep; 13(9):e066394. PubMed ID: 37734899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study.
    Fishbane S; Jadoul M; Dember L; Kovesdy CP; Al-Shurbaji A; Lisovskaja V; Sekar P; Katona B; Guzman N; Herzog C
    BMJ Open; 2023 May; 13(5):e071309. PubMed ID: 37230521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.
    Maggioni AP; Dondi L; Andreotti F; Calabria S; Iacoviello M; Gorini M; Gonzini L; Piccinni C; Ronconi G; Martini N
    Eur J Clin Invest; 2021 Aug; 51(8):e13551. PubMed ID: 33786826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis-the French Renal Epidemiology and Information Network registry.
    Mercadal L; Lambert O; Couchoud C; Metzger M; Edet S; Merle S; Jacquelinet C; Stengel B
    Nephrol Dial Transplant; 2021 Jan; 36(1):151-159. PubMed ID: 32582941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of patiromer and sodium polystyrene sulfonate on potassium levels in chronic haemodialysis patients: a randomized crossover trial.
    Jaques DA; Stucker F; Ernandez T; Alves C; Martin PY; De Seigneux S; Saudan P
    Clin Kidney J; 2022 Oct; 15(10):1908-1914. PubMed ID: 36158152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease.
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2019; 39(5):513-522. PubMed ID: 31027897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse gastrointestinal events with sodium polystyrene sulphonate and calcium polystyrene sulphonate use in dialysis patients: a nationwide registry study.
    Ferreira JP; Couchoud C; Edet S; Brunet P; Frimat L
    Nephrol Dial Transplant; 2021 Jan; 36(2):339-345. PubMed ID: 33247730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with the incidence and recurrence of hyperkalaemia in patients with cardiorenal conditions.
    Tafesse E; Hurst M; Hoskin L; Badora K; Sugrue D; Qin L; James G; McEwan P
    Int J Clin Pract; 2021 Apr; 75(4):e13941. PubMed ID: 33332710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.
    Desai NR; Rowan CG; Alvarez PJ; Fogli J; Toto RD
    PLoS One; 2020; 15(1):e0226844. PubMed ID: 31910208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.
    Haas JS; Krinke KS; Maas C; Hardt T; Barck I; Braun S
    BMC Nephrol; 2020 Aug; 21(1):332. PubMed ID: 32770956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world management of hyperkalemia with patiromer among United States Veterans.
    Kovesdy CP; Gosmanova EO; Woods SD; Fogli JJ; Rowan CG; Hansen JL; Sauer BC
    Postgrad Med; 2020 Mar; 132(2):176-183. PubMed ID: 31971043
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study).
    Boo AYY; Koh YLE; Hu PL; Tan NC
    BMJ Open; 2020 Sep; 10(9):e033755. PubMed ID: 32963061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis.
    Tsiagka D; Georgianos PI; Pikilidou MI; Vaios V; Roumeliotis S; Syrganis C; Mavromatidis K; Metallidis S; Liakopoulos V; Zebekakis PE
    Int Urol Nephrol; 2022 Sep; 54(9):2327-2334. PubMed ID: 35133576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients.
    Aslam S; Friedman EA; Ifudu O
    Nephrol Dial Transplant; 2002 Sep; 17(9):1639-42. PubMed ID: 12198216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.